Exploration of interethnic variation in the ibuprofen metabolizing enzyme CYP2C9: a genetic-based cautionary guide for treatment of COVID-19 symptoms

Ammar Ali Almarzooq

doi:10.1101/2021.01.09.21249508

Supplemental Table 1[supplements/249508_file07.xlsx]
Supplement Table 2[supplements/249508_file08.xlsx]
Supplement Table 3[supplements/249508_file09.xlsx]
Supplement Table 4[supplements/249508_file10.xlsx]
Supplement Table 5[supplements/249508_file11.xlsx]
Supplemental Table 6[supplements/249508_file12.xlsx]
Supplemental Table 7[supplements/249508_file13.xlsx]
Supplemental Table 8[supplements/249508_file14.xlsx]
Supplemental Table 9[supplements/249508_file15.xlsx]
Supplemental Table 10[supplements/249508_file16.xlsx]

Comments

medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions and read our Comment Policy before commenting. The content of a comment is not endorsed by medRxiv.

Community Reviews

medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors.

Community reviews for this article:

There are no community reviews for this paper.

Automated Evaluations

Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv.

Automated Evaluations:

There are no automated evaluations for this paper.

Exploration of interethnic variation in the ibuprofen metabolizing enzyme CYP2C9: a genetic-based cautionary guide for treatment of COVID-19 symptoms

Subject Area

Citation Manager Formats

Exploration of interethnic variation in the ibuprofen metabolizing enzyme CYP2C9: a genetic-based cautionary guide for treatment of COVID-19 symptoms

Subject Area

Follow this preprint